Saving the Lives of Thousands of Patients, Shanghai's Good Doctor: With Innovation and Dedication, Patients | Surgery | Shanghai

Release time:Apr 14, 2024 23:21 PM

Today, the 2023 "Shanghai Good Doctors" search and selection, sponsored by the Municipal Health Commission and the Municipal Health System Spiritual Civilization Construction Committee, and co sponsored by the Liberation Daily and the Shanghai Shangyi Medical Workers Award Foundation, has been officially announced. They are outstanding among the 88900 physicians in the city, always adhering to the clinical front line, serving patients with care and dedication, improving scientific research technology, exploring model reforms, and contributing to the construction of the Asian Medical Center in Shanghai.

They are highly skilled "goddess doctors"

In the eyes of the patient, Wang Chen is a superhero who can solve any problem. This beautiful female professor from the Department of Colorectal Surgery at Longhua Hospital has a bold and capable style of action. She uses her superb skills to solve countless patients' unspeakable problems, providing solutions for difficult and complicated patients in many parts of the country. She has also fought against necrotizing fasciitis multiple times in late night operating rooms, snatching lives from the hands of death.

Complex anal fistula is more difficult for patients than death. How to use the advantages of traditional Chinese medicine to find a breakthrough? Wang Chen inherits the essence of Gu's surgery and continuously innovates. Based on Professor Lu Jingen's "tunnel style suture technique", he integrates techniques such as suture padding, tube negative suction, anal fistula endoscopy, and laser closure to form Gu's unique traditional Chinese medicine external treatment comprehensive therapy, saving countless patients.

She always believed that "even if it's a little convenient for patients, our efforts are worth it." Based on this understanding, she not only delved into technology, but also led the team to continuously optimize various processes, shorten waiting time, facilitate follow-up and follow-up, and ultimately exchanged sweat for patient smiles. Now, Wang Chen has taken the lead in formulating three national and Shanghai guidelines, consensus, and norms. The century old inheritance of Gu's surgery has also collided with artificial intelligence to create dazzling sparks. The digital wound collection and management system, the Xiaokang Traditional Chinese Medicine Four Diagnosis Assistant, and the database management of anal fistula specialty will perfectly combine precision and minimally invasive techniques, shining with the brilliance of traditional Chinese medicine renewal.

Tuberculosis, an ancient but not far away respiratory infectious disease, has cast a shadow on many patients and families. For more than 20 years, Sha Wei, director of the Tuberculosis Department of Shanghai Pulmonary Hospital, has stuck to the forefront of tuberculosis diagnosis and treatment, not afraid of risks, solved problems for many patients at home and abroad, cured tens of thousands of difficult, severe and drug-resistant tuberculosis patients, and helped them return to society. She is patient, enthusiastic, and meticulous, often making correct judgments from various clues and providing effective treatment. She is affectionately known as the "Sand Goddess" by patients.

As the leader of tuberculosis diagnosis and treatment expert group in Shanghai, and the director of tuberculosis clinical medical research center, she led the diagnosis and treatment of drug-resistant tuberculosis in the city, and actively made scientific research and innovation, making tuberculosis epidemic control level in the city leading in the country; As a disease control consulting expert of the National Health Commission, I have compiled guidelines and provided suggestions for tuberculosis prevention and control strategies in China; As a member of the core group of the World Health Organization's Global Drug resistant tuberculosis Initiative, she has pushed the Chinese program to the world. While rooted in clinical practice, she has obtained 6 patents and insists on conducting public welfare activities such as free consultations and training in western and high-altitude areas every year, delivering patients to their homes.

They are the "climbers" who bravely venture into the peak of scientific research

"Many patients regard our place as their last hope, and we must shoulder this trust." Professor Yu Xianjun, the director of the Cancer Hospital, said that 13 years ago, when the department was just established, there were only 3 people and 7 beds. Now, the department has developed into the largest pancreatic tumor diagnosis and treatment center in Asia with 150 beds, 32 doctors, and an annual diagnosis and treatment volume of 50000 people. Behind these achievements is his deep cultivation from 8am to 12pm, which has helped alleviate the pain of over 3000 pancreatic cancer patients over the past decade.

The longer clinical work lasts, the more Yu Xianjun understands the importance of translational research. In order to improve surgical safety, he was inspired by the "mortise and tenon structure" and invented the "papillary stump closure type" pancreaticointestinal anastomosis, greatly reducing the incidence of postoperative pancreatic fistula and perioperative mortality. He innovated the pancreatic sharp lymph node dissection technology and invented five new devices for pancreatic surgery, which shortened the lymph node dissection time by 50% and reduced the local recurrence rate of pancreatic cancer by 30%. A series of innovations have extended the median survival period of the "king of cancer" pancreatic cancer by 40%, and the average medical cost of tumor hospitals has decreased by 10000 yuan compared with the average level in Shanghai. Now, according to the summary results of the Cancer Hospital, we have taken the lead in writing the Comprehensive Diagnosis and Treatment Guide for pancreatic cancer in China, and the "Shanghai Plan" for pancreatic cancer has been formed.

"Being the most cost-effective dental implant, minimizing patient pain, and reducing treatment costs." This is the unwavering wish of Lai Hongchang, director of the Dental Implant Department at the Ninth People's Hospital, who has been practicing medicine for more than 30 years. As an important promoter of the development of dental implant diagnosis and treatment in Shanghai and even across the country, he was the first to propose the theory of "effective bone fusion" internationally, and pioneered the establishment of a minimally invasive implant surgery model to help patients with alveolar bone atrophy recover their chewing function comfortably and efficiently. This surgical procedure significantly reduces postoperative pain scores and lowers treatment costs for patients. In addition, Lai Hongchang also took the lead in establishing a biological sample library for diseases around implants, constructing an early diagnostic system, and striving to provide patients with long-term stable and effective implant restoration.

Nowadays, Lai Hongchang has personally treated tens of thousands of patients, providing full mouth implant restoration for over a thousand elderly edentulous patients who have been seeking medical treatment. This not only restores chewing function, but also helps them regain confidence and smile. "Relying solely on my own strength is not enough. I hope different regions across the country can develop specialized dental implants." This year, he also promoted the development of the world's first internationally unified set of clinical evaluation indicators for dental implants, which is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants.

They are "experimenters" exploring healthcare reform

"June 24th, 2010, was the day Chongming came." Qin Li, the director of the Endocrinology Department at Chongming Hospital affiliated with Shanghai Health Medical College, still remembers clearly that he stayed that night, started working the next day, and has been rooted in the island for 13 years since then. As an expert dispatched by Xinhua Hospital to assist Chongming, Qin Li led his team to establish the first national standardized metabolic disease management center in Chongming District, the MMC grassroots management model of 1+X in Chongming District, and the first thyroid disease diagnosis and treatment center in Chongming District, playing a demonstrative and leading role in the construction of the Xinhua Chongming regional medical consortium.

To prevent major illnesses from leaving the island, Qin Li has successively opened specialized clinics for thyroid and gestational endocrine diseases, as well as thyroid MDT joint clinics, successfully diagnosing and treating multiple rare and difficult endocrine diseases. The first thyroid disease diagnosis and treatment center in Chongming District, led by her, has also formed a major feature of hospital specific disease diagnosis and treatment.

In 2011 and 2014, she completed the epidemiological and risk factors investigation and research on chronic metabolic diseases of 10000 people led by Academician Ning Guang in Chongming and the follow-up work three years later, which provided effective data for the collection of baseline data in the construction of the medical consortium, and also provided valuable basis for the prevention and control strategies of chronic diseases such as diabetes in Chongming.

The previous aortic arch surgery was a blank slate, with the lives of patients with acute aortic dissection hanging on the line. The surgery was described as a "fierce battle, night battle, bloody battle, and death battle". Professor Sun Lizhong, the medical director of Shanghai Deda Hospital, has successfully changed the surgical method and artificial blood vessel materials for aortic dissection, greatly reducing the incidence of secondary or multiple surgeries and surgical costs. He has created the "Sun's surgery" for 20 years, greatly saving medical insurance expenses and benefiting both the country and patients.

As a medical expert, Sun Lizhong also explores reforms in the medical model. He drew inspiration from the operation model of public hospitals and promoted greater medical technology space in non-public hospitals: Deda Hospital adopts a new hospital management model, focuses on the construction of technical team talents, improves technical level, from early handover and difficult case discussion to the development of new technologies and projects, all of which are beneficial for patients to fully devote themselves. Deda Hospital has established a "green channel for life" for emergency treatment of the heart and large blood vessels. Data shows that for patients with acute aortic dissection, the time from arrival at the hospital to the operating room does not exceed 1.5 hours, and the success rate of surgery is 96%. Last year, the hospital applied for certification from the China Chest Pain Center, and for the first time proposed using cases of acute aortic dissection as the scope of national level chest pain center certification, which was adopted, filling the gap in certification in the field of extracardiac care in China.

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended